Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
31.66 USD | +4.59% | +9.54% | -1.89% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.89% | 1.72B | |
+29.63% | 699B | |
+25.07% | 571B | |
-4.53% | 364B | |
+17.62% | 326B | |
+3.64% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.73% | 154B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Jefferies Downgrades Harmony Biosciences Holdings to Hold From Buy; Price Target is $57